Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126947312 | 12694731 | 2 | F | 20160826 | 20160829 | 20160906 | EXP | CN-SA-2016SA155949 | AVENTIS | HONGYAN H, XIANG Z, MING C. ANALYSIS OF INDIVIDUALIZED DRUG USE OF CLOPIDOGREL THROUGH DRUG GENETIC TESTING BY CLINICAL PHARMACISTS. CHINA PHARMACIST 2016;19(5):902-13. | 56.00 | YR | A | M | Y | 0.00000 | 20160906 | MD | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126947312 | 12694731 | 1 | PS | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Oral | Y | UNK | 20839 | 75 | MG | QD |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126947312 | 12694731 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126947312 | 12694731 | Bundle branch block right | |
| 126947312 | 12694731 | Chest discomfort | |
| 126947312 | 12694731 | Chest pain | |
| 126947312 | 12694731 | Myocardial infarction | |
| 126947312 | 12694731 | Vascular stent thrombosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |